🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Wow! An incredible surprise came my way today! I am honored to share that the Department of Medicine at Dartmouth has awarded me the Almy Professor’s Award for Excellence in Teaching, Fellow Recipient Dartmouth Health Geisel School of Medicine at Dartmouth 🙏🏼💚

"Currently, NCCN members cannot have a FCOI of more than $20,000 from a single entity or $50,000 from all external entities combined. However, we argue this amount should be 0." Endorse this wishlist from Dr. Nina Niu Sanford and Bishal Gyawali, MD, PhD, FASCO! ascopubs.org/doi/full/10.12… JCO Oncology Practice

Pleased to share our latest publication in Vaccine on the vaccine effectiveness of JYNNEOS vaccines (MVA-BN). Overall these are highly effective at preventing mpox. You can find the systematic review/meta analysis here: sciencedirect.com/science/articl…

1/n I am over the moon to announce I received my K23 award looking at the household transmission of influenza in low resource settings!

I'm thrilled to have my first oral presentation at #ASH24 A huge thank you to my incredible mentors Jan Bewersdorf, George Goshua, MD MSc, Kishan Patel, Maximilian Stahl, and Amer Zeidan MBBS,MHS ‏عامر زيدان for their unwavering support from day one. Excited to see everyone in San Diego! #Blood #Match2025

CRISPR therapies can treat disease but cost millions. An equity-based approach could bring them to more people. Read the new article from Kunal Potnis, MD and George Goshua, MD MSc: thebulletin.org/2024/10/crispr…

Excited to see this article with George Goshua, MD MSc out in Bulletin of the Atomic Scientists, where we explore how adding a health equity lens to valuation can help harness the potential of gene therapies around the world Yale School of Medicine Yale Internal Medicine Yale IM Traditional Residency Program Mark D. Siegel

New research from Daniel Wang Yale School of Medicine and the lab of George Goshua, MD MSc YaleHematology at #ASH24 shows that universal screening for iron deficiency is cost effective and would improve QoL for women. Smilow Cancer Hospital Yale New Haven Hosp hematology.org/newsroom/press…

Daniel Wang of the George Goshua, MD MSc Lab will share a cost-effective analysis for screening women for #irondeficiency at #ASH24, today at 2pm PT/5pm ET. ash.confex.com/ash/2024/webpr… Smilow Cancer Hospital Yale School of Medicine Yale New Haven Hosp YaleHematology

Study data presented at #ASH24 showed that a higher ferritin threshold than that used by WHO and CDC is cost-effective for identifying and treating women with iron deficiency. Healio spoke with George Goshua, MD MSc of Yale School of Medicine and Yale Cancer Center about the data. healio.com/news/hematolog…

Samira Glaeser-Khan Yale School of Medicine ‘28 presents new research from the lab of George Goshua, MD MSc at #ASH24 demonstrating the value of prophylaxis emicizumab for infants with severe Hemophilia A and showing cost effectiveness of a low dose. YaleHematology Yale New Haven Hosp

.Lauren Merz presents a case for universal Duffy testing in infants to mitigate the long-term patient impact of Duffy null phenotype, ⬇️ ANC & healthcare costs #ASH24, mentored by George Goshua, MD MSc YaleHematology Yale School of Medicine ASH American Academy of Pediatrics

Daniel Wang at the podium #ASH24 presenting important research summarizing the cost-effectiveness of iron screening in women of reproductive age. YaleHematology George Goshua, MD MSc Yale School of Medicine ASH

"It finally became possible to put forward an economic risk-benefit argument for why we should consider screening and treating on a population level." George Goshua, MD MSc on new data presented at #ASH24 supporting iron screening in women of reproductive age. ASH Healio

.Karthik Chetlapalli demonstrates non-myeloablative/reduced intensity allotranplantation offers the most cost effective option for long-term treatment for #sicklecelldisease #SCD #ASH24. George Goshua, MD MSc YaleHematology Smilow Cancer Hospital Yale School of Medicine OncoAlert ash.confex.com/ash/2024/webpr…

.Kunal Potnis, MD reveals that at the current pricing, eltrombopag plus traditional immunosuppressive therapy is unlikely to be a cost-effective treatment for adults with severe aplastic anemia in the US. #ASH24 George Goshua, MD MSc YaleHematology Smilow Cancer Hospital ash.confex.com/ash/2024/webpr…

Dr Abdulrahman Alhajahjeh, MD did an outstanding job to present on behalf of the Yale Cancer Center group & George Goshua, MD MSc lab the results of our cost effectiveness of transplant in intermediate risk #AMLsm at #ASH24 #IMG

Dr Jessica M. Stempel fantastically presented our investigator-initiated randomized phase 2 trial of aza-ven +/- Pembro in older #AMLsm #ASH24 which was unfortunately -ve but showed importance of using ELN2024 for risk stratification & feasibility of central MRD in primary endpoint #IMG

Drs. Barbara Lam & George Goshua George Goshua, MD MSc moderated an important session #ASH24 with 6 important presentations highlighting innovative approaches to improve care for understudied, non-malignant Hematologic Diseases. #hematology YaleHematology ASH

Our robust research tracks kicked off with an introductory Cancer Epidemiology & Outcomes track dinner at Il Gabbiano. Excellent dinner and even better company including our APD, Dr. Podoltsev, our tracks leaders, Dr. Ma, Dr. Dinan & Dr. Goshua, and current and future fellows!